Clinical Trials Logo
  1. Home
  2. Ischemic Stroke
  3. NCT04637074
  4. Details
NCT04637074 Clinical Trial

A Cohort Study on Thrombectomy for Stroke

Ischemic Stroke Clinical Trial

Official title:
Registrated Cohort Study on Thrombectomy for Stroke

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04637074
Other study ID # MRCTA, ECFAH of FMU [2020]389
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2020
Est. completion date December 30, 2025

Study information
Verified date November 2021
Source First Affiliated Hospital of Fujian Medical University
Contact Ying M Fu, MD
Phone +8613920263688
Email fuying@fjmu.eu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The cerebral collateral circulation refers to the subsidiary network of vascular channels that stabilize cerebral blood flow when principal conduits fail. Collateral status differs among patients with acute ischemic stroke. Relatively sparse attention has been devoted to the role of baseline collateral circulation in patients with acute ischemic stroke who are candidates for revascularization. This study aim to investigate the correlation between baseline collateral circulation and the likelihood of opening of an arterial occlusion, the extent of reperfusion, tissue injury and clinical impairment.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date December 30, 2025
Est. primary completion date December 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Age = 18 years. - Mechanical thrombectomy initiated within 24 hours after onset - CT perfusion can be performed before the initiation of thrombectomy and 24h after thrombectomy Exclusion Criteria: - Contraindication to imaging with contrast agents - Delay between imaging and beginning of thrombectomy > 90 minutes

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Department of Neurology, First Affiliated Hospital of Fujian Medical University Fuzhou

Sponsors (1)
Lead Sponsor Collaborator
Ning Wang, MD., PhD.

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Modified Rankin Scale Good functional outcome will be defined by a Modified Rankin Scale of 0-2, 3 months after stroke onset 3 month
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06462599 - Osteopontin Gene Polymorphism in Stroke Patients in Egypt
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A